Skip to main content

Peer Review reports

From: Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis

Original Submission
26 Oct 2022 Submitted Original manuscript
6 Nov 2022 Author responded Author comments - Zhijian Zheng
Resubmission - Version 2
6 Nov 2022 Submitted Manuscript version 2
8 Nov 2022 Author responded Author comments - Zhijian Zheng
Resubmission - Version 3
8 Nov 2022 Submitted Manuscript version 3
1 Dec 2022 Reviewed Reviewer Report
9 Jan 2023 Reviewed Reviewer Report
15 Jan 2023 Reviewed Reviewer Report
21 Feb 2023 Author responded Author comments - Zhijian Zheng
Resubmission - Version 4
21 Feb 2023 Submitted Manuscript version 4
22 Feb 2023 Reviewed Reviewer Report
23 Feb 2023 Reviewed Reviewer Report
23 Feb 2023 Reviewed Reviewer Report
7 Mar 2023 Author responded Author comments - Zhijian Zheng
Resubmission - Version 5
7 Mar 2023 Submitted Manuscript version 5
Publishing
9 Mar 2023 Editorially accepted
3 Apr 2023 Article published 10.1186/s12916-023-02826-6

You can find further information about peer review here.

Back to article page